title: Benefits and risks of ovarian function and reproduction for cancer development and prevention.
abstract: Ovarian function and menstrual cycle disturbances, pregnancy, and reproductive medicine procedures can either increase gynecological cancer risk or prevent cancer development. For ovarian cancer development, there are two hypotheses, which are connected with ovulation and gonadotropin secretion. Most of the ovarian cancers seem to be derived from displaced ovarian surfice epithelial cells. One year of ovulatory cycles increases the ovarian cancer risk by 6%. Ovulation between 22 and 29 years of age causes the highest risk increase per year. In contrast, progesterone or progestins appear to create protection. Lifestyle can affect or modify ovarian cancer risk. Breast cancer risk is very much related to age of menarche and menopause, pregnancy, and breast feeding. All of which are related to ovarian function and progestogenic impact that translates either into breast cancer risk increase or decrease. This is modified by body mass index, physical activity, and lifestyle in general. The risk of endometrial cancer is most closely related to endogenous progesterone during the menstrual cycle and pregnancy or by exogenous progestogens as in oral contraceptives. These effects are progestogen dose and time dependent. Endometrial cancer risk can also be increased by estrogen-producing tumors or long-term estrogen treatment.
authors.affiliation: Institute for Medical Research and Education, Essen, Germany. adolf.schindler@uni-due.de
authors.forename: Adolf E
authors.initials: AE
authors.lastname: Schindler
mesh_terms: D001943:Breast Neoplasms / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D002277:Carcinoma / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000209:etiology* / Q000235:genetics / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D010053:Ovary / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D011247:Pregnancy; D012098:Reproduction / Q000235:genetics / Q000502:physiology*; D018570:Risk Assessment; D012307:Risk Factors